HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Clinical trials for HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA explained in plain language.
Never miss a new study
Get alerted when new HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA trials appear
Sign up with your email to follow new studies for HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New registry tracks Real-World safety of cholesterol drug lomitapide
Disease control CompletedThis observational registry followed 260 patients with homozygous familial hypercholesterolemia (a severe genetic condition causing very high cholesterol) who were taking lomitapide. The goal was to monitor long-term safety, especially liver problems and gastrointestinal issues, …
Matched conditions: HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Sponsor: Amryt Pharma • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug SHR-1918 targets stubborn high cholesterol in rare disease
Disease control CompletedThis Phase 3 trial tested the drug SHR-1918 in 55 people with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing extremely high cholesterol. Participants received either the drug or a placebo, and researchers measured how much their LDL (bad) choles…
Matched conditions: HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Phase: PHASE3 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New drug shows promise for rare High-Cholesterol disease
Disease control CompletedThis phase 2 trial tested an investigational drug called SHR-1918 in 26 people with homozygous familial hypercholesterolemia (HoFH), a rare genetic condition causing extremely high cholesterol. The study measured how much the drug lowered LDL (bad) cholesterol after 12 weeks. All…
Matched conditions: HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
Phase: PHASE2 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 26, 2026 13:33 UTC